Journal of Human Immunity (JHI) is the official open access journal of the International Alliance for Primary Immunodeficiency Societies (IAPIDS). Published by @rupress.org 🌐 jhumimmunity.org
Journal of Human Immunity
🌐 Journal of Human Immunity (JHI) is now officially indexed in #PubMed Central and PubMed. This includes all future papers and the complete back catalog dating back to our first issue. Read the full announcement and explore the journal here: rupress.org/jhi/pages/pm...
Publishing in JHI enables authors funded by National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI), and other funders an easy pathway to compliance. Learn more:
👉 rupress.org/pages/nih-hh...
🔔 We're delighted to share the Abstracts from the 9th Scientific Meeting of the Japanese Society for Immunodeficiency & Autoinflammatory Diseases (JSIAD), which took place Feb. 14–15, 2026, in Sendai. Explore the latest advancements in #IEIs clinical practice & research
👉 rupress.org/jhi/issue/2/...
Human germline biallelic loss-of-function OSMR variants cause severe allergic disease. New study from Simran Samra, Mehul Sharma, Stuart E. Turvey @turveylab.bsky.social and colleagues:
rupress.org/jhi/article/...
#Immunology #Genetics #Atopy #IEIs #InbornErrorsOfImmunity
News & Views: A new report in JHI from Catak et al. (rupress.org/jhi/article/...) deepens our understanding of human disease associated with loss of #CTLA4. Helen C. Su @niaidnews.bsky.social discusses the findings: rupress.org/jhi/article/...
How I Treat: #STAT3 hyper IgE syndrome. Clinical management guidelines proposed by Cliodhna Murray, Eyad Jannoud, Seraina Prader, and Bodo Grimbacher @uni-freiburg.de:
rupress.org/jhi/article/...
#HowITreat #InbornErrorsOfImmunity #IEIs
Mehmet Cihangir Catak, Bernice Lo, Safa Baris et al. describe the first case of homozygous #CTLA4 deficiency, which drives severe early-onset #autoimmunity through profound T and B cell dysregulation. rupress.org/jhi/article/...
#ClinicalPhenotypes #Diagnostics #Therapeutics
A major milestone for @jhumimmunity.org with PubMed and PubMed Central indexing. We are building a home for outstanding human immunology—from fundamental discovery to clinical translation with a focus on monogenic disorders—and look forward to the next generation of exciting submissions.
I’m delighted to see @jhumimmunity.org achieve PubMed and PubMed Central indexing. This is an important milestone for the journal and for the field. I look forward to seeing more outstanding studies in human immunology and immune-mediated disease submitted to JHI.
Really happy with this new paper just published in @jhumimmunity.org
